Every day, we handpick the 5 Top Stories stock market investors need to know. In 5 minutes, you’ll learn the stocks, CEOs, and money managers moving markets.
Shots Fired as EV War Hots Up
In one of the most aggressive moves yet seen in the Chinese electric vehicle (EV) price wars, BYD [1211:HK] has put a discount on almost all of its EVs and hybrids, under the slogan “electricity is cheaper than oil”. The firm is hoping to steal market share from legacy automakers such as Toyota [TM], according to Bloomberg. Elsewhere, Xiaomi [1810:HK] is poised to launch what its CEO Lei Jun says is the “best-looking, easiest-to-drive and smartest car” priced below RMB500,000.
Can the Vision Pro Compete in China?
During his visit to China, Apple [AAPL] CEO Tim Cook said that the Vision Pro headset will launch in the country later this year, CNBC reported. It will compete with local players, among them ByteDance-owned Pico. Meanwhile, the European Commission said on Monday that Apple’s and Google’s [GOOGL] app store rules will be the target of a probe under the Digital Markets Act.
China to Phase Out Foreign Hardware
Beijing has put in place new guidelines which will phase out the use of processors made by US firms, among them Intel [INTC] and AMD [AMD], in government computers and servers, reported the Financial Times. Foreign-made software, including Microsoft’s [MSFT] Windows, will also be phased out. China has been making moves to boost its domestic semiconductor industry while becoming less dependent on foreign technology.
Open-source Challenge to Nvidia
“We’re actually showing developers how you migrate out from an Nvidia platform,” Vinesh Sukumar, Head of AI and Machine Learning at Qualcomm [QCOM], told Reuters. Qualcomm is part of the UXL Foundation, a coalition of tech firms aiming to break Nvidia’s [NVDA] dominance in artificial intelligence (AI). The foundation is developing open-source software and tools that will be able to power different types of AI accelerator chips.
Stocks Rise as Biosecure Sponsor Stands Down
US Congressman Mike Gallagher has said he will step down from Congress next month. As he is chairman of the committee sponsoring the Biosecure Act, which aims to tighten controls over Chinese biotechs, the news sent up the share prices of two firms that stood to suffer under it: WuXi Biologics [2269.HK] and its sister company WuXi AppTec [2359.HK] rose 7.7% and 4.9%, respectively.
Disclaimer Past performance is not a reliable indicator of future results.
CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.
The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.
CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.
*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.
Continue reading for FREE
- Includes free newsletter updates, unsubscribe anytime. Privacy policy
